CD16A binding agents and uses thereof

Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various con...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Iben, Lawrence G, Spiegel, David Adam, Bunin, Anna, Manion, Douglas, Welsch, Matthew Ernest
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Iben, Lawrence G Spiegel, David Adam Bunin, Anna Manion, Douglas Welsch, Matthew Ernest
description	Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11572370B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11572370B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11572370B23</originalsourceid><addsrcrecordid>eNrjZFB1djE0c1RIysxLycxLV0hMT80rKVZIzEtRKC1OLVYoyUgtSs1P42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoam5kbG5gZORsbEqAEAxFAmQA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CD16A binding agents and uses thereof</title><source>esp@cenet</source><creator>Iben, Lawrence G ; Spiegel, David Adam ; Bunin, Anna ; Manion, Douglas ; Welsch, Matthew Ernest</creator><creatorcontrib>Iben, Lawrence G ; Spiegel, David Adam ; Bunin, Anna ; Manion, Douglas ; Welsch, Matthew Ernest</creatorcontrib><description>Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230207&DB=EPODOC&CC=US&NR=11572370B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230207&DB=EPODOC&CC=US&NR=11572370B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Iben, Lawrence G</creatorcontrib><creatorcontrib>Spiegel, David Adam</creatorcontrib><creatorcontrib>Bunin, Anna</creatorcontrib><creatorcontrib>Manion, Douglas</creatorcontrib><creatorcontrib>Welsch, Matthew Ernest</creatorcontrib><title>CD16A binding agents and uses thereof</title><description>Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB1djE0c1RIysxLycxLV0hMT80rKVZIzEtRKC1OLVYoyUgtSs1P42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoam5kbG5gZORsbEqAEAxFAmQA</recordid><startdate>20230207</startdate><enddate>20230207</enddate><creator>Iben, Lawrence G</creator><creator>Spiegel, David Adam</creator><creator>Bunin, Anna</creator><creator>Manion, Douglas</creator><creator>Welsch, Matthew Ernest</creator><scope>EVB</scope></search><sort><creationdate>20230207</creationdate><title>CD16A binding agents and uses thereof</title><author>Iben, Lawrence G ; Spiegel, David Adam ; Bunin, Anna ; Manion, Douglas ; Welsch, Matthew Ernest</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11572370B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Iben, Lawrence G</creatorcontrib><creatorcontrib>Spiegel, David Adam</creatorcontrib><creatorcontrib>Bunin, Anna</creatorcontrib><creatorcontrib>Manion, Douglas</creatorcontrib><creatorcontrib>Welsch, Matthew Ernest</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Iben, Lawrence G</au><au>Spiegel, David Adam</au><au>Bunin, Anna</au><au>Manion, Douglas</au><au>Welsch, Matthew Ernest</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CD16A binding agents and uses thereof</title><date>2023-02-07</date><risdate>2023</risdate><abstract>Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US11572370B2
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title	CD16A binding agents and uses thereof
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A33%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Iben,%20Lawrence%20G&rft.date=2023-02-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11572370B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true